% | $
Quotes you view appear here for quick access.

Seattle Genetics, Inc. Message Board

  • mghmd mghmd Jan 12, 2013 5:51 PM Flag

    Dana Farber Best of ASH Conference 1/12/13 Waltham, Ma.

    I attended today and brentuximab was discussed at length and favorably. No question that it will start to play a large role in the Rx of T cell lymphoma. They also thought it very likely would find its way into front line Rx for HD patients with poor prognostic factors and/or bulky disease. However, they didn't think it was likely to be used in the majority of front line patients because of $$ and mild-moderate toxicity issues.

50.33-0.05(-0.10%)Oct 26 4:00 PMEDT